Filing Details

Accession Number:
0001214659-16-014641
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-11-14 18:36:04
Reporting Period:
2016-11-09
Filing Date:
2016-11-14
Accepted Time:
2016-11-14 18:36:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1649989 Oncobiologics Inc. ONS Biological Products, (No Disgnostic Substances) (2836) 383982704
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1663253 A. Scott Gangloff C/O Oncobiologics, Inc.
7 Clarke Drive
Cranbury NJ 08521
Svp, Development & Mfrg No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Restricted Stock Units Disposition 2016-11-09 115,942 $0.00 0 No 4 C Direct
Common Stock Acquisiton 2016-11-09 115,942 $0.00 115,942 No 4 M Direct
Common Stock Disposition 2016-11-11 37,369 $3.75 78,573 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 M Direct
No 4 S Direct
Footnotes
  1. Granted pursuant to the Issuer's 2015 Equity Incentive Plan.
  2. Each restricted stock unit ("RSU") represents the right to receive, at settlement, one (1) share of the Issuer's common stock.
  3. The RSUs vest upon the first to occur of (x) a change of control as defined in the award agreement and (y) the expiration of the 6 month lock-up period following the Issuer's initial public offering, in each case subject to continued service through such event.
  4. Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on November 9, 2016. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person.